BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 8772240)

  • 1. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
    Paloma MJ; Páramo JA; Rocha E
    Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
    Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E
    Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].
    Paloma MJ; Páramo JA; Rifón J; Rocha E
    Sangre (Barc); 1992 Dec; 37(6):435-8. PubMed ID: 1293794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.
    Gómez C; Páramo JA; Colucci M; Rocha E
    Thromb Haemost; 1989 Sep; 62(2):694-8. PubMed ID: 2683190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of DDAVP on endotoxin-induced intravascular coagulation in rabbits.
    Paloma MJ; Páramo JA; Rocha E
    Thromb Haemost; 1992 Sep; 68(3):306-9. PubMed ID: 1440497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
    J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
    Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
    Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization.
    Rahman F
    Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies.
    Rondeau E; Mougenot B; Lacave R; Peraldi MN; Kruithof EK; Sraer JD
    Clin Nephrol; 1990 Feb; 33(2):55-60. PubMed ID: 2107050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.
    Carr ME; Krishnamurti C; Alving BM
    Thromb Haemost; 1992 Jan; 67(1):106-10. PubMed ID: 1615464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1.
    Montes R; Declerck PJ; Calvo A; Montes M; Hermida J; Muñoz MC; Rocha E
    Thromb Haemost; 2000 Jul; 84(1):65-70. PubMed ID: 10928472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
    Ramsby ML; Kreutzer DL
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 18. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
    Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
    Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.